Despite Liability, Sales Risks, GSK Stands Tall On Sinking Avandia Ship
Executive Summary
The Senate Finance Committee staff report charging that GlaxoSmithKline and FDA mishandled safety information related to the diabetes drug Avandia probably doesn't change the sales and liability challenges facing the firm in managing the product, but it does make them more acute.